Iowa Caucus Success for Tom Steyer is to Exceed Expectations (The Gazette) CEDAR RAPIDS – California businessman Tom Steyer says he plans to spend...
Keep Reading →
December 27 - Hedge Funds, Insider Trading - Comments
SunPower Corporation (NASDAQ:SPWR) (The Motley Fool) What happened: Shares of solar manufacturer SunPower Corp. (NASDAQ:SPWR) fell as much as 12.4% in...
Keep Reading →
February 15 - Market Movers, News - Comments
No doubt, penny stocks are for investors with a greater than average risk appetite, but considering their inexpensiveness and the possibility of towering...
Keep Reading →
March 26 - Hedge Funds, News - Comments
Both Antares Pharma Inc (NASDAQ:ATRS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) recently had their names attached to 13G forms, as two hedge...
Keep Reading →
September 10 - Hedge Funds, News - Comments
In two separate filings with the U.S. Securities and Exchange Commission, Armistice Capital, led by Steven Boyd, disclosed massively cutting its activist...
Keep Reading →
September 3 - Hedge Funds, News - Comments
According to a recent filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has trimmed its stake in Antares...
Keep Reading →
June 17 - Hedge Funds, News - Comments
Shares of drug delivery systems manufacturer Unilife Corp (NASDAQ:UNIS) recently rallied after it announced a long-term contract to sell prefilled syringes...
Keep Reading →
September 18 - News - Comments
In the 21st century investor’s toolkit, there are a multitude of methods shareholders can use to track Mr. Market. Some of the most underrated are hedge...
Keep Reading →
September 3 - News - Comments
Recently, I enjoyed an article contributed by Adam Feuerstein (“AF article”) regarding Antares Pharma Inc (NASDAQ:ATRS) and its transformational...
Keep Reading →
July 5 - News - Comments
It’s hard to believe, but 2013 is already more than halfway over. This year has been a good one for many pharmaceutical stocks — at least...
Keep Reading →
July 3 - News - Comments
Is Antares Pharma Inc (NASDAQ:ATRS) undervalued? The best stock pickers are getting more bullish. The number of long hedge fund positions advanced by...
Keep Reading →
June 19 - News - Comments
Following the publication of my article on the blockbuster potential of Antares Pharma Inc (NASDAQ:ATRS)‘s transformational product (Otrexup),...
Keep Reading →
June 13 - News - Comments
Merit Medical Systems, Inc. (NASDAQ:MMSI) was in 11 hedge funds’ portfolio at the end of the first quarter of 2013. MMSI has seen a decrease in...
Keep Reading →
June 6 - News - Comments
Antares Pharma Inc (NASDAQ:ATRS) announced its first-quarter results Wednesday morning but failed to impress the market. Shares were down around 3%...
Keep Reading →
May 8 - News - Comments
Sequester or no sequester, the folks at the Food and Drug Administration look to be quite busy in 2013. Their schedules are full with plenty of important...
Keep Reading →
March 25 - News - Comments
When building your portfolio, aim for diversification. You should aim to hold both large and small companies (plus mid-sized ones) and companies in a...
Keep Reading →
March 20 - News - Comments
Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report...
Keep Reading →
March 11 - News - Comments
